1. Home
  2. PPSI vs NEPH Comparison

PPSI vs NEPH Comparison

Compare PPSI & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pioneer Power Solutions Inc.

PPSI

Pioneer Power Solutions Inc.

HOLD

Current Price

$4.04

Market Cap

51.4M

Sector

Industrials

ML Signal

HOLD

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$3.67

Market Cap

45.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PPSI
NEPH
Founded
2008
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.4M
45.3M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
PPSI
NEPH
Price
$4.04
$3.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$12.00
$6.00
AVG Volume (30 Days)
149.4K
44.2K
Earning Date
11-13-2025
03-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.86
0.14
Revenue
$31,751,000.00
$17,930,000.00
Revenue This Year
$26.84
$33.32
Revenue Next Year
$10.26
$12.27
P/E Ratio
$1.43
$29.53
Revenue Growth
105.82
32.36
52 Week Low
$2.25
$1.39
52 Week High
$5.70
$6.42

Technical Indicators

Market Signals
Indicator
PPSI
NEPH
Relative Strength Index (RSI) 38.66 35.36
Support Level $3.87 $3.74
Resistance Level $4.48 $4.10
Average True Range (ATR) 0.32 0.28
MACD -0.07 -0.04
Stochastic Oscillator 5.05 0.00

Price Performance

Historical Comparison
PPSI
NEPH

About PPSI Pioneer Power Solutions Inc.

Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: